MiraVista Aims to Improve Testing for Misdiagnosed Infections

Posted: Updated:
The company expects to expand even more quickly as it develops a new rapid test for histoplasmosis. The company expects to expand even more quickly as it develops a new rapid test for histoplasmosis.

Histoplasmosis isn’t top of mind for most people, but if you’re a Hoosier, it’s likely that you’ve had it. MiraVista Diagnostics Medical Director and President Dr. Lawrence Joseph Wheat says about half of people living in Indiana have had histoplasmosis, an infection caused by a fungus that can be found in soil containing large amounts of bird or bat droppings. Building on nearly two decades of infectious disease testing, the Indianapolis-based company is on the cusp of major growth that could make detecting fungal infections faster and more efficient.

The Centers for Disease Control and Prevention (CDC) says people can get histoplasmosis after breathing in the microscopic fungal spores from the air. Although most who breathe in the spores don’t get sick, Wheat says the infection can be dangerous for people with weakened immune systems. It’s most common in the Midwest, and Wheat says it’s likely about 90 percent of people living in Tennessee have had the infection.

“[Diagnostics] are really important in areas where these fungal infections are seen,” says Wheat. “If these tests aren’t available, there are [immunocompromised] patients who would die without treatment, or would be much sicker by the time they’re diagnosed and have a more difficult response to treatment.”

Wheat says MiraVista performs the bulk of fungal infection testing for the U.S. Humans comprise about two-thirds of its testing, but the company also tests veterinary patients. Most samples arrive at the Indianapolis facility from reference labs and academic medical centers throughout the country.

Wheat developed the proprietary test in the late 1980s as an infectious disease specialist at the Indiana University School of Medicine. He left the university in 2002 to start MiraVista, which began with just five employees, but has now grown to 50.

The company is anticipating to expand even more quickly as it develops a new kind of test for histoplasmosis. Unlike the enzyme assay that requires high-tech equipment in MiraVista’s clinical lab, Wheat says the new diagnostic “is a rapid test, like a pregnancy test that can be performed in the local lab on small numbers of samples.”

A trial testing MiraVista’s rapid diagnostic is underway in Latin America, with a second scheduled to start soon. Wheat says the standard method in Latin America to detect histoplasmosis is to examine a tissue sample under a microscope, which can be a barrier for easy diagnosis.

“There’s probably more histoplasmosis in Latin America than the U.S.,” says Wheat. “It’s common in most Latin American countries, so a rapid test will be very important there. We’re going to put a lot of emphasis on [the trials] in the next two years to try to make [the rapid test] available there.”

While most of its work focuses on histoplasmosis, MiraVista also tests for blastomycosis and coccidioidomycosis, more commonly known as Valley fever, which can be severe even in healthy people. The National Institutes of Health awarded a grant to MiraVista to also develop a rapid test for Valley fever.

The CDC says about 10,000 cases of Valley fever are reported each year, mostly in the Southwest, but tens of thousands more likely occur and are misdiagnosed, because many patients are not tested for the condition.

Wheat says the company’s growth over the last two years has enabled it to work on demanding projects, such as expanding to Latin America. He expects the number of employees at MiraVista to double—reaching 100—in the next two years as it implements new tests and further develops diagnostics in its pipeline.

“We are doubling the size of our building and recruiting more scientists who can bring new ideas to research. We have facilities here to manufacture kits, develop kits and add new services,” says Wheat. “Our veterinarian practice is probably only a quarter of what it could be, once we implement better marketing. We have a lot going on this year we think will take us to another level.”

Wheat says missing a diagnosis for fungal infections such as histoplasmosis or Valley fever can be extremely dangerous, especially for patients with weakened immune systems.
Wheat says Americans’ awareness of fungal infections is relatively low, but health officials in the Southwest are trying to educate the public about coccidioidomycosis (Valley fever).
  • Perspectives

    • (Image courtesy of Bedel Financial Consulting Inc.)

      Child Identity Theft: Are Your Children at Risk?

      Sounds absurd, doesn't it? However, young children are prime targets for identity theft. Experian estimates that one of every four children will fall victim to identity theft before age 18. How does this happen? More importantly, how can you prevent it from happening to your child? Untangling child identity theft can be time-consuming and costly. It could even require changing your child's first and middle name and obtaining a new Social Security number to clear his/her credit record...
    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • The Union Club Hotel was built in 1929. (photo courtesy of Purdue University)

      $30M Gift to Fund Purdue Hotel Renovation

      Purdue University says it plans to use a $30 million gift to transform an existing building into a world-class hotel. The gift from Bruce White, a Purdue alumnus and former trustee, his wife Beth, and the Dean and Barbara White Foundation, will fund the renovation of the Union Club Hotel, which will also serve as a laboratory learning environment for students. The university says the renovations will feature upgrades in furnishings, fixtures, and amenities for the hotel, as well as a...
    • Red Line Rapid Transit Project Progressing

      As construction continues on the high-profile, $96 million Red Line Rapid Transit Project in central Indiana, the director of public relations at IndyGo says ongoing, system-wide investments are already bearing fruit. The first phase of the Red Line will run between Broad Ripple and the University of Indianapolis and the public transportation organization says it will "serve as the frequent spine of the improved and reliable grid network." Lauren Day says ridership...

    • The trip marked Holcomb's seventh economic development trip as governor.

      Indiana Opens Italian Office

      As part of an economic development mission to Italy, Indiana has opened a business development office in Milan. During the three-day trip, members of the delegation also met with businesses in Italy's "Motor Valley" to promote collaboration with the state's automotive manufacturing and motorsports industries. During the trip, delegation members joined Italy-based filter manufacturer Filtrec S.p.A. for its announcement that it will invest $1.3 million into a Daleville...

    • Milhaus Details Purchase of Harrison College Indy Campus

      Indianapolis-based Milhaus says it plans to build a 183-unit apartment complex on a portion of the campus of recently-closed Harrison College. The development, construction and management company purchased the property last month for $6.3 million and Marketing Director Raven Reckley says the college's decision to close was "news to us." She adds Milhaus is "disappointed for the students and staff who are affected most" and will be evaluating...

    • Indiana Lands $21M in Opioid Treatment Funding

      Two Indiana agencies have received more than $21 million in federal funding. The grants will be used for opioid treatment services throughout the state. The grant was awarded through the HHS' Substance Abuse and Mental Health Services Administration. FSSA Secretary Jennifer Walthall says the funds are "crucial as we continue bolstering our evidence-based prevention, treatment and recovery services, expand access to recovery housing and medication-assisted treatment, and work to...